METADATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metadate, and what generic alternatives are available?
Metadate is a drug marketed by Aytu Biopharma and Lannett Co Inc and is included in three NDAs.
The generic ingredient in METADATE is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metadate
A generic version of METADATE was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METADATE?
- What are the global sales for METADATE?
- What is Average Wholesale Price for METADATE?
Summary for METADATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Drug Prices: | Drug price information for METADATE |
| DailyMed Link: | METADATE at DailyMed |
US Patents and Regulatory Information for METADATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aytu Biopharma | METADATE CD | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021259-003 | May 27, 2003 | AB2 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Lannett Co Inc | METADATE ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 040306-001 | Oct 20, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aytu Biopharma | METADATE CD | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021259-004 | Feb 19, 2006 | AB2 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
